RESPIRATORY CHARACTERISTICS IN A COHORT OF CHILDREN WITH SPINAL MUSCULAR ATROPHY TYPE 1 RECEIVING NUSINERSEN

被引：0
|
作者：
Xiao, Lena
Chiang, Jackie
Gonorazky, Hernan
Boyd, Jennifer
Amrani, Fatema
Qashqari, Hebah
Amin, Reshma
机构：
来源：
CHEST | 2020年 / 158卷 / 04期
关键词：
D O I：
10.1016/j.chest.2020.08.1992
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：2347A / 2348A
页数：2
相关论文
共 50 条
  • [31] Exploring the Influence of Concurrent Nutritional Therapy on Children with Spinal Muscular Atrophy Receiving Nusinersen Treatment
    Pinar, Eymen
    Ayvaz, Bilal Berke
    Akkus, Erkan
    Ulkersoy, Ipek
    Dilek, Tugce Damla
    Zindar, Yilmaz
    Ulug, Fitnat
    Guzeler, Aysel
    Kilic, Huseyin
    Guler, Serhat
    Beser, Omer Faruk
    Saltik, Sema
    Cullu Cokugras, Fugen
    CHILDREN-BASEL, 2024, 11 (08):
  • [32] Immunization status of patients with spinal muscular atrophy receiving nusinersen therapy
    Yesilmen, Mehmet Can
    Gunay, Cagatay
    Uzan, Gamze Sarikaya
    Ozsoy, Ozlem
    Kurul, Semra Hiz
    Yis, Uluc
    ARCHIVES DE PEDIATRIE, 2023, 30 (05): : 291 - 296
  • [33] Evolution of bulbar function in spinal muscular atrophy type 1 treated with nusinersen
    Weststrate, Harriet
    Stimpson, Georgia
    Thomas, Lily
    Scoto, Mariacristina
    Johnson, Emily
    Stewart, Alexandra
    Muntoni, Francesco
    Baranello, Giovanni
    Conway, Eleanor
    DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2022, 64 (07): : 907 - 914
  • [34] Changing respiratory expectations with the new disease trajectory of nusinersen treated spinal muscular atrophy [SMA] type 1
    Fitzgerald, Dominic A.
    Doumit, Michael
    Abel, Francois
    PAEDIATRIC RESPIRATORY REVIEWS, 2018, 28 : 11 - 17
  • [35] Intrathecal Nusinersen in Older Children and Adults with Spinal Muscular Atrophy
    Veerapandiyan, A.
    Eichinger, K.
    Guntrum, D.
    Kwon, J.
    Collins, E.
    Ciafaloni, E.
    ANNALS OF NEUROLOGY, 2019, 86 : S130 - S130
  • [36] Nusinersen: A Treatment for Spinal Muscular Atrophy
    Claborn, Melanie K.
    Stevens, Debra L.
    Walker, Cheri K.
    Gildon, Brooke L.
    ANNALS OF PHARMACOTHERAPY, 2019, 53 (01) : 61 - 69
  • [37] NUSINERSEN IN THE TREATMENT OF SPINAL MUSCULAR ATROPHY
    Sinko Gabriella
    Kiss Zsuzsanna
    Kalman Bernadette
    IDEGGYOGYASZATI SZEMLE-CLINICAL NEUROSCIENCE, 2018, 71 (3-4): : 90 - 94
  • [38] Outcomes in type 1 spinal muscular atrophy on nusinersen: A single center experience
    Zhang, Chao
    Figueroa, Janet
    Ritchey, Mary
    Razdan, Raj
    Verma, Sumit
    CLINICAL NEUROPHYSIOLOGY, 2020, 131 (12) : 2793 - 2794
  • [39] Single-center experience with intrathecal administration of Nusinersen in children with spinal muscular atrophy type 1
    Pechmann, Astrid
    Langer, Thorsten
    Wider, Sabine
    Kirschner, Janbernd
    EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2018, 22 (01) : 122 - 127
  • [40] Nusinersen treatment of older children and adults with spinal muscular atrophy
    Konersman, Chamindra G.
    Ewing, Emily
    Yaszay, Burt
    Naheedy, John
    Murphy, Susan
    Skalsky, Andrew
    NEUROMUSCULAR DISORDERS, 2021, 31 (03) : 183 - 193
12345